Exhibit 99.5
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the Ordinary Shares, par value £0.01 per share, of Summit Therapeutics PLC, a foreign private issuer incorporated in England and Wales. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
/s/ Mahkam Zanganeh | |||
Mahkam Zanganeh | |||
MAHKAM ZANGANEH REVOCABLE TRUST | |||
SHAUN ZANGANEH IRREVOCABLE TRUST | |||
By: | /s/ Mahkam Zanganeh | ||
Name: | Mahkam Zanganeh | ||
Title: | Trustee |